期刊文献+

枸橼酸莫沙比利治疗动力障碍型功能性消化不良的临床效果 被引量:6

The clinical effect of mosapride citrate on gastric motility disorders form of functional dyspepsia
暂未订购
导出
摘要 目的探讨枸橼酸莫沙比利治疗动力障碍型功能性消化不良的疗效及安全性。方法52例动力障碍型功能性消化不良患者随机分为两组,治疗组26例,给予枸橼酸莫沙比利5mg,3次/d治疗4周;对照组26例,给予西沙比利5mg,3次/d治疗4周。分别于治疗前及治疗4周后观察两组的症状变化,比较两组的临床疗效及不良反应。结果两组治疗4周后均可明显改善动力障碍型功能性消化不良患者上腹胀、早饱、食欲不振、嗳气、恶心或呕吐等症状,与治疗前相比有显著性差异(P<0.05);治疗组治疗前症状总积分为8.20±1.69,治疗后为1.68±1.41,二者有显著性差异(P<0.01),治疗组总有效率为92.31%;对照组治疗前症状总积分为8.10±1.71,治疗后为1.81±1.13,也有显著性差异(P<0.01),对照组总有效率为88.46%。两组治疗前后症状总积分及总有效率比较均无显著性差异(P>0.05)。两组患者治疗后均未出现明显不良反应。结论枸橼酸莫沙比利是治疗动力障碍型功能性消化不良一种安全、有效的药物。 Objective To investigate the clinical effect and safety of mosapride citrate on gastric motility disorders form of functional dyspepsia. Methods Fifty-two patients with gastric motility disorders form of functional dyspepsia were randomly divided into 2 groups. Mosapride citrate(5mg three times daily for 4 weeks) was given to 26 patients in the treatment group, cisapride (5mg three times daily for 4 weeks) to 26 patients in the control group.Dyspepsia symptoms were evaluated before treatment and later 4 weeks after treatment. The clinical and adverse reactions were compared between 2 groups.Results After 4 weeks treatment symptoms of both groups including abdominal distention,early satiety, anorexia, belching, nausea or vomiting in patients with gastric motility disorders form of functional dyspepsia had been improved, and symptoms scores were significantly decreased (P〈0.01). The scores of the symptoms of treatment group before and after the treatment were 8.20±1.69 and 1.68±1.41 respectively (P〈0.01), the total effective rates were 92.31%. The scores of the symptoms of control group before and after the treatment were 8.10±1.71 and 1.81±1.13 respectively(P〈0.01),the total effective rates were 88.46%.There were no significant differences in the total effective rates and symptoms scores before treatment and later 4 weeks after treatment between 2 groups (P〈0.05). 1% serious adverse reactions were found in 2 groups.Conclusion Mosapride citrate is an effective and safe drug in the treatment of gastric motility disorders form of functional dyspepsia.
出处 《实用医药杂志》 2006年第4期404-406,共3页 Practical Journal of Medicine & Pharmacy
关键词 功能性消化不良 枸橼酸莫沙比利 胃动力障碍型 Functional dyspepsia Mosapride citrate Gastric motility disorders
  • 相关文献

参考文献8

  • 1侯晓华.消化道运动学[M].北京:科学出版社,1997.271.
  • 2Douglas A.Rome Ⅱ the functional gastrointestinal disorders.2nd ed.Degnon Associates,Mclean,VA,2000.
  • 3刘新光.功能性消化不良与胃肠动力异常[J].中华消化杂志,2002,22(1):44-44.
  • 4Stanghellini V.Review article:pain versus discomfort is differentiation clinically useful?Aliment Pharmacol Ther,2001,15:145
  • 5Stanghellini V,Tosetti C,Paternico A,et al.Predominant symptoms identify different subgroups in functional dyspepsia.Am J Gastroenterol,1999,94:2080
  • 6陈露,李昌平.功能性消化不良的病因研究进展[J].临床消化病杂志,2003,15(4):187-189. 被引量:17
  • 7柯美云,蓝宇,王智风,邢进宏.功能性消化不良昼夜胃内pH变化[J].临床消化病杂志,1995,7(3):97-100. 被引量:13
  • 8王宝恩,梁晓梅,贾博琦,陈宝雯,柯美云,林三仁,丁士刚,张锦坤,施礼,张志宏,陈隆典,徐家裕,袁耀宗,阮美娟,刘厚钰,邱德凯,张达荣,李增烈,欧阳钦,王一平,李瑜元,吴惠生,胡家露,姜若兰,王莜如,梁有信.西沙必利治疗功能性消化不良的多中心临床疗效观察[J].中华内科杂志,1995,34(3):180-184. 被引量:113

二级参考文献2

  • 1A. M. Caballero-Plasencia PhD,M. C. Muros-Navarro PhD,J. L. Martin-Ruiz PhD,M. Valenzuela-Barranco PhD,M. C. Los Reyes-Garcia MD,R. Vilchez-Joya PhD,F. J. Casado-Caballero MD,B. Gil-Extremera PhD. Gastroparesis of digestible and indigestible solids in patients with insulin-dependent diabetes mellitus or functional dyspepsia[J] 1994,Digestive Diseases and Sciences(7):1409~1415
  • 2柯美云,谷成明,姜玉新,朱昭辉,张淑琴,王智凤,李方.消化不良患者的胃幽门十二指肠运动协调性研究[J].中国医学科学院学报,2000,22(3):240-244. 被引量:26

共引文献237

同被引文献51

  • 1聂志余.卒中后胃肠道功能障碍与营养支持[J].中国卒中杂志,2006,1(11):786-789. 被引量:7
  • 2胡伏莲.消化性溃疡发病机制的现代理念[J].中华消化杂志,2005,25(3):189-190. 被引量:257
  • 3Sonnenberg A, Koch TR. Physician visits in the United States for constipation: 1958 to 1986 [J]. Dig Dis Sci, 1989, 34 (4): 606-611.
  • 4Baker DE. Rationale for using serotonergic agents to treat irritable bowel syndrome [J]. Am J Health Syst Pharm, 2005, 62 (7): 700-711, 712-713.
  • 5Gershon MD. Review article: serotonin receptors and transporter \ . . s-roles in normal and abnormal gastrointestinal motility [J]. Ali- ment Pharmacol Ther, 2004, 20 Suppl 7: 3-14.
  • 6Degen L, Matzinger D, Merz M, et al. Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gas- trointestinal transit in healthy male subjects [J]. Aliment Phar- macolTher, 2001, 15 (11): 1745-1751.
  • 7Degen'L, Petrig C, Studer D, et al. Effect of tegaserod on gut transit in male and female subjects [J]. Neurogastroenterol Motil, 2005, 17 (6): 821-826.
  • 8Schikowski A, Thewissen M, Mathis C, etal. Serotonin type-4 receptors modulate the sensitivity of intramural mechano- receptive afferents of the cat rectum [J]. Neurogastroenterol Motil, 2002, 14 (3): 221-227.
  • 9Coelho A, Rovira P, Fioramonti J, et al. Antinociceptive properties of HTF 919 (tegaserod), a 5-HT4 receptor partial agonist, on colorectal distension in rats [J]. Gastroenterology, 2000, 118 (4): A835.
  • 10Mohammad S, Zhou Z, Gong Q, et al. Blockage of the HERG human cardiac K + channel by the gastrointestinal pro- kinetic agent cisapride [J]. Am JPhysiol, 1997, 273 (SPt 2): H2534-H2538.

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部